[AKRO] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -32.06%
YoY- -37.60%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -28,933 -15,090 -29,711 -21,403 -16,207 -11,886 -15,611 50.94%
Tax -50 -50 -11 -6 -1,323 -1,237 -46 5.72%
NP -28,933 -15,090 -29,711 -21,403 -16,207 -11,886 -15,611 50.94%
Tax Rate - - - - - - - -
Total Cost 28,933 15,090 29,711 21,403 16,207 11,886 15,611 50.94%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.83 -0.43 -0.86 -0.63 -0.57 -0.42 -0.55 31.59%
EPS Diluted -0.83 -0.43 -0.86 -0.63 -0.57 -0.42 -0.55 31.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.